Tularemia in Central Anatolia
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Tularemia is a bacterial zoonosis with diverse clinical manifestations depending on bacterial subspecies and the route of the infection.
We collected data prospectively of cases diagnosed and treated for tularemia in our institution during the epidemics from December 2009 to August 2011. Specific antibodies were screened by a microagglutination test. Throat swab and lymph node aspirate cultures were obtained and polymerase chain reaction (PCR) was performed on these specimens. Lymph nodes were characterized on the basis of ultrasound reports.
A total of 139 patients were confirmed with tularemia. The age range of the patients was 6–83 years (mean: 43) and 84 (60.4 %) of them were females. Patients had clinical presentations compatible with oropharyngeal (74 %), glandular (15.8 %), and oculoglandular (5.0 %) tularemia. Ultrasonography (US) was performed in 108 patients. Antibiotics (aminoglycosides, quinolones, and doxycycline) were used in 138 patients. Fine-needle aspiration (FNA) or surgical drainage of fluctuant lymph nodes were performed in 51 (39 %) patients. Therapeutic failure was observed in 43 (30.9 %) patients. Elevation of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were observed to be significantly higher in patients with therapeutic failures (p = 0.003 and 0.004, respectively). The success rate was significantly higher in patients with early treatment (p = 0.004). No difference was found between the effectiveness of aminoglycoside or quinolone treatments. The increase in the short and long axes, and the characteristics of lymph nodes detected on US were significantly associated with treatment failures (p < 0.001). Intranodal necrosis was found in 45 patients. The treatment success rate was 40 % in patients with intranodal necrosis.
To the best of our knowledge, this is the first study defining the US findings of patients with tularemia and its association with treatment success. Ciprofloxacin is an effective and convenient choice in epidemics of tularemia and early treatment is still the cornerstone of successful therapies.
- Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15:631–46. CrossRef
- Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1–29. CrossRef
- Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci. 2007;1105:378–404. CrossRef
- Kılıç S. A general overview of Francisella tularensis and the epidemiology of tularemia in Turkey. Flora Derg. 2010;15:37–58.
- Reintjes R, Dedushaj I, Gjini A, et al. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis. 2002;8:69–73. CrossRef
- Chitadze N, Kuchuloria T, Clark DV, et al. Water-borne outbreak of oropharyngeal and glandular tularemia in Georgia: investigation and follow-up. Infection. 2009;37:514–21. CrossRef
- Kantardjiev T, Ivanov I, Velinov T, et al. Tularemia outbreak, Bulgaria, 1997–2005. Emerg Infect Dis. 2006;12:678–80. CrossRef
- Akalin H, Helvaci S, Gedikoğlu S. Re-emergence of tularemia in Turkey. Int J Infect Dis. 2009;13:547–51. CrossRef
- Helvaci S, Gedikoğlu S, Akalin H, Oral HB. Tularemia in Bursa, Turkey: 205 cases in ten years. Eur J Epidemiol. 2000;16:271–6. CrossRef
- Gürcan S, Otkun MT, Otkun M, Arikan OK, Ozer B. An outbreak of tularemia in Western Black Sea region of Turkey. Yonsei Med J. 2004;45:17–22.
- Karadenizli A, Gurcan S, Kolayli F, Vahaboglu H. Outbreak of tularaemia in Golcuk, Turkey in 2005: report of 5 cases and an overview of the literature from Turkey. Scand J Infect Dis. 2005;37:712–6. CrossRef
- Celebi G, Baruönü F, Ayoğlu F, et al. Tularemia, a reemerging disease in Northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis. 2006;59:229–34.
- Willke A, Meric M, Grunow R, et al. An outbreak of oropharyngeal tularaemia linked to natural spring water. J Med Microbiol. 2009;58:112–6. CrossRef
- Ulu Kılıç A, Kılıç S, Sencan I, et al. A water-borne tularemia outbreak caused by Francisella tularensis subspecies holarctica in Central Anatolia region. Mikrobiyol Bul. 2011;45:234–47.
- Sjöstedt A, Kuoppa K, Johansson T, Sandström G. The 17 kda lipoprotein and encoding gene of Francisella tularensis lvs are conserved in strains of Francisella tularensis. Microb Pathog. 1992;13:243–9. CrossRef
- Khanna R, Sharma AD, Khanna S, Kumar M, Shukla RC. Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy. World J Surg Oncol. 2011;9:29. CrossRef
- Ahuja AT, Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol. 2005;184:1691–9. CrossRef
- Cutler SJ, Fooks AR, van der Poel WH. Public health threat of new, reemerging, and neglected zoonoses in the industrialized world. Emerg Infect Dis. 2010;16:1–7. CrossRef
- Coker R, Rushton J, Mounier-Jack S, et al. Towards a conceptual framework to support one-health research for policy on emerging zoonoses. Lancet Infect Dis. 2011;11:326–31. CrossRef
- Tärnvik A, Priebe HS, Grunow R. Tularaemia in Europe: an epidemiological overview. Scand J Infect Dis. 2004;36:350–5. CrossRef
- Meric M, Willke A, Finke EJ, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS. 2008;116:66–73. CrossRef
- Tärnvik A. WHO Guidelines on Tularaemia. WHO/CDS/EPR/2007.7. Geneva: World Health Organization (WHO), 2007. http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_7.pdf.
- Maurin M, Pelloux I, Brion JP, Del Banõ JN, Picard A. Human tularemia in France, 2006–2010. Clin Infect Dis. 2011;53:e133–41. CrossRef
- Hepburn MJ, Simpson AJ. Tularemia: current diagnosis and treatment options. Expert Rev Anti Infect Ther. 2008;6:231–40. CrossRef
- Yesilyurt M, Kiliç S, Celebi B, et al. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey. J Antimicrob Chemother. 2011;66:2588–92. CrossRef
- Coşkun O, Erdem H, Avci A. Management of community-acquired acute bacterial cystitis in Turkey. Turk J Med Sci. 2011;41:149–57.
- Tularemia in Central Anatolia
Volume 41, Issue 2 , pp 391-399
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Central Turkey
- US findings
- Industry Sectors
- Author Affiliations
- 1. Department of Infectious Diseases and Clinical Microbiology (IDCM), Erciyes School of Medicine, Talas-Kayseri, Turkey
- 2. Department of Infectious Diseases and Clinical Microbiology (IDCM), Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
- 3. Bacterial Zoonoses Reference Laboratory, Public Health Institution of Turkey (PHIT), Ankara, Turkey